InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Kulkarni Samarth, 董事长兼首席执行官. Officer active across 1 company, notably CRISPR Therapeutics AG. Cumulatively, 51 filings have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €3.9m. Activity tracked since 1 June 2021. The latest transaction was filed on 20 January 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Kulkarni Samarth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报51 总计
19,687 股Common SharesSEC:0001193125-26-122272:0
20,625 股Common SharesSEC:0001193125-26-111278:0
19,250 股Common SharesSEC:0001193125-26-104480:0
13,250 股Common SharesSEC:0001193125-26-061712:0
21,433 股@ US$51.618.1% 占其流量Common SharesSEC:0001193125-26-019733:0
30,000 股0Common SharesSEC:0001193125-25-329010:0
100,000 股Common SharesSEC:0001193125-25-243819:0
8,334 股Common SharesSEC:0001193125-25-240438:0
6,000 股0Common SharesSEC:0001193125-25-209353:0
25,000 股Common SharesSEC:0001682019-25-000003:0
19,688 股Common SharesSEC:0000950170-25-043975:0
19,250 股Common SharesSEC:0000950170-25-038216:0
18,360 股@ US$55.2058.5% 占其流量Common SharesSEC:0000950170-25-025000:0
13,250 股Common SharesSEC:0000950170-25-023385:0
13,751 股@ US$16.211.9% 占其流量Common SharesSEC:0000950170-24-140846:0
15,000 股@ US$55.10436.8% 占其流量Common SharesSEC:0000950170-24-133373:0
23,121 股@ US$55.4310.4% 占其流量Common SharesSEC:0000950170-24-126521:0
8,333 股Common SharesSEC:0000950170-24-114786:0
100,000 股0Common SharesSEC:0000950170-24-095615:0
19,582 股@ US$19.123.1% 占其流量Common SharesSEC:0000950170-24-045196:0
20,000 股@ US$19.123.1% 占其流量Common SharesSEC:0000950170-24-032989:0
19,250 股Common SharesSEC:0000950170-24-030189:0
13,250 股Common SharesSEC:0000950170-24-018174:0
20,000 股@ US$19.123.1% 占其流量Common SharesSEC:0000950170-24-016574:0
50,000 股@ US$19.127.7% 占其流量Common SharesSEC:0000950170-24-009505:0
51 条申报中的 25 条
About Kulkarni Samarth
Kulkarni Samarth is Président-Directeur Général and Chief Executive Officer at CRISPR Therapeutics AG. Across 51 total filings, the 51 sampled filings cover the period from 2021-06-03 to 2026-03-24, with 0 EUR of buys and 3900377 EUR of sells, and the most common transaction nature is Levée d'options.
